Readystate Asset Management LP Abbott Laboratories Call Options Transaction History

Readystate Asset Management LP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $10.8 Million - $12.7 Million	107,500 Added 1954.55%	113,000 $12.9 Billion
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $11.2 Million - $12.5 Million	-111,600 Reduced 95.3%	5,500 $572 Million
Q1 2024 May 10, 2024	BUY	$109.52 - $120.96 $10.7 Million - $11.8 Million	97,900 Added 509.9%	117,100 $13.3 Billion
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $1.73 Million - $2.12 Million	19,200 New	19,200 $2.11 Billion
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $280,894 - $330,629	2,900 New	2,900 $294 Million

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $202B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Readystate Asset Management LP, based on Form 13F filings with the SEC.

Stay updated on Readystate Asset Management LP with notifications on news.